Successful treatment of psoriasis with risankizumab in a patient with telangiectasia macularis eruptiva perstans
- PMID: 35647249
- PMCID: PMC9136246
- DOI: 10.1016/j.jdcr.2022.04.015
Successful treatment of psoriasis with risankizumab in a patient with telangiectasia macularis eruptiva perstans
Keywords: TMEP, elangiectasia macularis eruptiva perstans; biologics; cutaneous mastocytosis; malignancy; plaque psoriasis; risankizumab; systemic mastocytosis; telangictasia macularis eruptiva perstans.
Conflict of interest statement
Cara Barber has no conflicts of interest to report. Dr. Eingun James Song, MD, has been a consultant, speaker or investigator for the following companies: AbbVie, Janssen, Amgen, Lilly, SUN, UCB, Incyte, Novartis, Sanofi & Regeneron, Castle Biosciences, and Pfizer.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources